Category: Venerology
-
Astria Therapeutics to Present at Upcoming European Academy of Dermatology and Venerology Congress By Investing.com
•
BOSTON–(BUSINESS WIRE)–Asteria Therapeutics, Inc. (Nasdaq: ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immune diseases, today announced that it will present preliminary data for nafinibart alfa-star at the upcoming European Academy of Dermatology & Venereology (EADV) Congress in Amsterdam, the Netherlands on September 26, 2024. Dr.…